Purdue Pharma and the Opioid Addiction Crisis

Purdue Pharma and the Opioid Addiction Crisis

VRIO Analysis

A few years ago, Purdue Pharma was in the news for something they hadn’t intended. The CEO of the company had resigned after being accused of using questionable marketing strategies in marketing the drug OxyContin. The issue here was that Purdue Pharma, along with its subsidiary Purdue Pharma L.P. Was accused of knowingly misleading doctors and patients about the addictive nature of OxyContin, and their marketing tactics targeting low-income communities to get the most profit out

Alternatives

For many years Purdue Pharma, the maker of the highly addictive opioid drug OxyContin, used fraudulent marketing tactics to market the drug to healthcare professionals as an effective pain medication for chronic pain. The truth is different. The drug’s main ingredient, Oxycodone, is derived from opium poppy, a highly addictive drug that has been used for thousands of years as a pain reliever. According to a report from The Lancet, one in four deaths from op

Recommendations for the Case Study

Purdue Pharma is a drug manufacturer based in New Haven, Connecticut, which is famous for the brand name OxyContin, used for pain management and over-the-counter medications. hbr case study analysis Purdue Pharma’s company history starts from the late 1950s. In the late 1990s, Purdue Pharma faced significant challenges due to the growing epidemic of prescription painkillers, especially OxyContin. The company’s market share declined as consumers moved to non-prescription

Problem Statement of the Case Study

I work for Purdue Pharma, and I’ve been monitoring the Opioid Addiction crisis ever since I started my career at the company over 15 years ago. I started as an engineer and worked my way up to my current role as Executive Vice President of Regulatory Affairs and Business Development. Here’s what I’ve observed so far: I’ve seen Purdue Pharma develop an unprecedented opioid addiction crisis. As a company, I’ve always been aware of the risk of opioid addiction and its

Case Study Analysis

Opioid addiction is a major crisis in the US. The number of opioid-related deaths increased from 37,257 in 1999 to 68,061 in 2019. It is caused by the abuse of prescription opioid painkillers, which are designed to alleviate pain, and heroin. According to the National Institute on Drug Abuse (NIDA), opioids are effective and pain-relieving medications, but overprescribing and addiction

Marketing Plan

Purdue Pharma (Purdue) was established in 1931 in St. Louis, Missouri, in the United States. The company started as a manufacturer of pharmaceuticals but gradually moved into the production of synthetic opioids and later into the synthetic painkiller OxyContin. In 2007, Purdue Pharma and its parent company, Bayer AG, were charged with the manufacturing of OxyContin and marketing it as a prescription painkiller without ade

SWOT Analysis

Purdue Pharma, formerly known as OxyContin, is the second-largest opioid manufacturer in the United States. It is not a new entity in the pharmaceutical industry; however, the recent opioid addiction crisis has raised concern about the company’s responsibility for the situation. Company History: Purdue Pharma was founded in 1885 as the Philadelphia Oxy-Contin Company. In the 1960s, the company was acquired by Bayer and rebranded as Oxy